Interview With Roche Holding AG CEO Severin Schwan

Severin Schwan, chief executive officer of Roche Holding AG, gestures during an interview at the company's headquarters in Basel, Switzerland, on Wednesday, Dec. 21, 2011. Roche Holding AG's Zelboraf treatment for a specific type of melanoma was recommended for approval by the European Union's drug regulator. Photographer: Gianluca Colla/Bloomberg via Getty Images
Severin Schwan, chief executive officer of Roche Holding AG, gestures during an interview at the company's headquarters in Basel, Switzerland, on Wednesday, Dec. 21, 2011. Roche Holding AG's Zelboraf treatment for a specific type of melanoma was recommended for approval by the European Union's drug regulator. Photographer: Gianluca Colla/Bloomberg via Getty Images
Interview With Roche Holding AG CEO Severin Schwan
PURCHASE A LICENCE
How can I use this image?
AED 1,850.00
AED

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
136048760
Collection:
Bloomberg
Date created:
21 December, 2011
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ROCHE HOLDING CEO